Renner, S.* ; Martins, A.S.* ; Streckel, E.* ; Braun-Reichhart, C.* ; Backman, M.* ; Prehn, C. ; Klymiuk, N.* ; Bähr, A.* ; Blutke, A. ; Landbrecht-Schessl, C.* ; Wünsch, A.* ; Kessler, B.* ; Kurome, M.* ; Hinrichs, A.* ; Koopmans, S.J.* ; Krebs, S.* ; Kemter, E.* ; Rathkolb, B. ; Nagashima, H.* ; Blum, H.* ; Ritzmann, M.* ; Wanke, R.* ; Aigner, B.* ; Adamski, J. ; Hrabě de Angelis, M. ; Wolf, E.*
Mild maternal hyperglycemia in INSC93S transgenic pigs causes impaired glucose tolerance and metabolic alterations in neonatal offspring.
Dis. Model. Mech. 12:dmm039156 (2019)
Alongside the obesity epidemic, the prevalence of maternal diabetes is rising worldwide, and adverse effects on fetal development and metabolic disturbances in the offspring's later life have been described. To clarify whether metabolic programming effects are due to mild maternal hyperglycemia without confounding obesity, we investigated wild-type offspring of INSC93S transgenic pigs, which are a novel genetically modified large-animal model expressing mutant insulin (INS) C93S in pancreatic beta-cells. This mutation results in impaired glucose tolerance, mild fasting hyperglycemia and insulin resistance during late pregnancy. Compared with offspring from wildtype sows, piglets from hyperglycemic mothers showed impaired glucose tolerance and insulin resistance (homeostatic model assessment of insulin resistance: +3-fold in males; +4.4-fold in females) prior to colostrum uptake. Targeted metabolomics in the fasting and insulin-stimulated state revealed distinct alterations in the plasma metabolic profile of piglets from hyperglycemic mothers. They showed increased levels of acylcarnitines, gluconeogenic precursors such as alanine, phospholipids (in particular lysophosphatidylcholines) and a-aminoadipic acid, a potential biomarker for type 2 diabetes. These observations indicate that mild gestational hyperglycemia can cause impaired glucose tolerance, insulin resistance and associated metabolic alterations in neonatal offspring of a large-animal model born at a developmental maturation status comparable to human babies.
Impact Factor
Scopus SNIP
Web of Science
Times Cited
Scopus
Cited By
Altmetric
Publikationstyp
Artikel: Journalartikel
Dokumenttyp
Wissenschaftlicher Artikel
Typ der Hochschulschrift
Herausgeber
Schlagwörter
Maternal Diabetes ; Pig ; Transgenic ; Developmental Programming ; Metabolomics; Insulin-resistance; Fetal; Associations; Mutations; Markers; Obesity; Models; Growth; Mutant
Keywords plus
Sprache
englisch
Veröffentlichungsjahr
2019
Prepublished im Jahr
HGF-Berichtsjahr
2019
ISSN (print) / ISBN
1754-8403
e-ISSN
1754-8411
ISBN
Bandtitel
Konferenztitel
Konferzenzdatum
Konferenzort
Konferenzband
Quellenangaben
Band: 12,
Heft: 8,
Seiten: ,
Artikelnummer: dmm039156
Supplement: ,
Reihe
Verlag
Company of Biologists
Verlagsort
Bidder Building, Station Rd, Histon, Cambridge Cb24 9lf, England
Tag d. mündl. Prüfung
0000-00-00
Betreuer
Gutachter
Prüfer
Topic
Hochschule
Hochschulort
Fakultät
Veröffentlichungsdatum
0000-00-00
Anmeldedatum
0000-00-00
Anmelder/Inhaber
weitere Inhaber
Anmeldeland
Priorität
Begutachtungsstatus
Peer reviewed
POF Topic(s)
30201 - Metabolic Health
30505 - New Technologies for Biomedical Discoveries
30205 - Bioengineering and Digital Health
Forschungsfeld(er)
Genetics and Epidemiology
Enabling and Novel Technologies
PSP-Element(e)
G-505600-003
G-500600-001
G-500692-001
A-630600-001
G-500390-001
Förderungen
Copyright
Erfassungsdatum
2019-07-24